The important role of von Willebrand factor in platelet‐derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|7|1301-1309

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.7, 2015-07, pp. : 1301-1309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Von Willebrand Factor-Specific Antibodies Developing upon Treatment of FVIII-Deficient Mice with Different FVIII Preparations

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-07 ,pp. : 244-247

Karger

Access to resources Recommend Favorite

Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Platelet-Derived Growth Factor Receptor in Eotaxin Signaling of Eosinophils

By  

International Archives of Allergy and Immunology, Vol. 140, Iss. 1, 2006-06 ,pp. : 28-34

Karger

Access to resources Recommend Favorite

Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A

By  

Acta Haematologica, Vol. 121, Iss. 2-3, 2009-06 ,pp. : 102-105

Karger

Access to resources Recommend Favorite

The Role of Platelet-Derived Growth Factor-B/Platelet-Derived Growth Factor Receptor-β Signaling in Chronic Atrial Fibrillation

By  

Cardiology, Vol. 133, Iss. 4, 2016-01 ,pp. : 242-256

Karger

Access to resources Recommend Favorite